{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T21:12:26Z","timestamp":1771017146753,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T00:00:00Z","timestamp":1400112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s10067-014-2669-0","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T07:49:55Z","timestamp":1400053795000},"page":"1383-1388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The role of interferon-gamma release assays in predicting the emergence of active tuberculosis in the setting of biological treatment: a case report and review of the literature"],"prefix":"10.1007","volume":"35","author":[{"given":"Rossana","family":"Scrivo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Sauzullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Mengoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Riccieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso Maria","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Cantoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Vullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio Maria","family":"Mastroianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Valesini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,15]]},"reference":[{"issue":"8","key":"2669_CR1","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","volume":"48","author":"JJ G\u00f3mez-Reino","year":"2003","unstructured":"G\u00f3mez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD, BIOBADASER Group (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk. Arthritis Rheum 48(8):2122\u20132127","journal-title":"Arthritis Rheum"},{"issue":"15","key":"2669_CR2","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor \u03b1-neutralizing agent. N Engl J Med 345(15):1098\u20131104","journal-title":"N Engl J Med"},{"issue":"9","key":"2669_CR3","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","volume":"38","author":"RS Wallis","year":"2004","unstructured":"Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO (2004) Granulomatous infection diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38(9):1261\u20131265","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2669_CR4","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1136\/annrheumdis-2012-201979","volume":"71","author":"KL Winthrop","year":"2012","unstructured":"Winthrop KL, Weinblatt ME, Daley CL (2012) You can't always get what you want, but if you try sometimes (with two tests\u2014TST and IGRA\u2014for tuberculosis) you get what you need. Ann Rheum Dis 71(11):1757\u20131760","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2669_CR5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3899\/jrheum.120688","volume":"40","author":"R Scrivo","year":"2013","unstructured":"Scrivo R, Sauzullo I, Mengoni F et al (2013) Mycobacterial interferon-\u03b3 release variations during long-term treatment with tumor necrosis factor blockers: lack of correlation with clinical outcome. J Rheumatol 40(2):157\u2013165","journal-title":"J Rheumatol"},{"issue":"4","key":"2669_CR6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3343\/kjlm.2011.31.4.271","volume":"31","author":"KH Kim","year":"2011","unstructured":"Kim KH, Lee SW, Chung WT et al (2011) Serial interferon-gamma release assays for the diagnosis of latent tuberculosis infection in patients treated with immunosuppressive agents. Korean J Lab Med 31(4):271\u2013278","journal-title":"Korean J Lab Med"},{"issue":"3","key":"2669_CR7","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/ar3882","volume":"14","author":"G Hatemi","year":"2012","unstructured":"Hatemi G, Melikoglu M, Ozbakir F, Tascilar K, Yazici H (2012) Quantiferon-TB Gold in tube assay for the screening of tuberculosis before and during treatment with tumor necrosis factor alpha antagonists. Arthritis Res Ther 14(3):R147","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"2669_CR8","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1111\/j.1468-3083.2011.04220.x","volume":"26","author":"S Garcovich","year":"2012","unstructured":"Garcovich S, Ruggeri A, D'Agostino M et al (2012) Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study. J Eur Acad Dermatol Venereol 26(12):1572\u20131576","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"2669_CR9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s13555-013-0020-3","volume":"3","author":"L Drago","year":"2013","unstructured":"Drago L, Nicola L, Signori V et al (2013) Dynamic QuantiFERON response in psoriasis patients taking long-term biologic therapy. Dermatol Ther (Heidelb) 3(1):73\u201381","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"5","key":"2669_CR10","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/bjd.12544","volume":"169","author":"I Sauzullo","year":"2013","unstructured":"Sauzullo I, Mengoni F, Marocco R et al (2013) IFN-\u03b3 release assay for tuberculosis in psoriasis patients treated with TNF antagonists: in vivo and in vitro analysis. Br J Dermatol 169(5):1133\u20131140","journal-title":"Br J Dermatol"},{"issue":"2","key":"2669_CR11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/annrheumdis-2011-200489","volume":"71","author":"DY Chen","year":"2012","unstructured":"Chen DY, Shen GH, Chen YM, Chen HH, Hsieh CW, Lan JL (2012) Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNF\u03b1 inhibitors: the utility of IFN\u03b3 assay. Ann Rheum Dis 71(2):231\u2013237","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2669_CR12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10238-010-0123-4","volume":"11","author":"X Xie","year":"2011","unstructured":"Xie X, Chen JW, Li F, Tian J, Gao JS, Zhang D (2011) A T-cell-based enzyme-linked immunospot assay for tuberculosis screening in Chinese patients with rheumatic diseases receiving infliximab therapy. Clin Exp Med 11(3):155\u2013161","journal-title":"Clin Exp Med"},{"issue":"1","key":"2669_CR13","first-page":"111","volume":"31","author":"M Klein","year":"2013","unstructured":"Klein M, Jaro\u0161ov\u00e1 K, Forejtov\u00e1 \u0160 et al (2013) Quantiferon TB Gold and tuberculin skin tests for the detection of latent tuberculosis infection in patients treated with tumour necrosis factor alpha blocking agents. Clin Exp Rheumatol 31(1):111\u2013117","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"2669_CR14","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1371\/journal.pmed.0040208","volume":"4","author":"M Pai","year":"2007","unstructured":"Pai M, O\u2019Brien R (2007) Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions? PLoS Med 4(6):e208","journal-title":"PLoS Med"},{"issue":"6","key":"2669_CR15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S1473-3099(07)70086-5","volume":"7","author":"M Pai","year":"2007","unstructured":"Pai M, Dheda K, Cunningham J, Scano F, O\u2019Brien R (2007) T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis 7(6):428\u2013438","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"2669_CR16","first-page":"84","volume":"13","author":"M Pai","year":"2009","unstructured":"Pai M, Joshi R, Dogra S et al (2009) T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis 13(1):84\u201392","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"2669_CR17","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1164\/rccm.200511-1783OC","volume":"174","author":"K Ewer","year":"2006","unstructured":"Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, Lalvani A (2006) Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 174(7):831\u2013839","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"2669_CR18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1086\/499311","volume":"193","author":"KA Wilkinson","year":"2006","unstructured":"Wilkinson KA, Kon OM, Newton SM et al (2006) Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens. J Infect Dis 193(3):354\u2013359","journal-title":"J Infect Dis"},{"key":"2669_CR19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1465-9921-8-5","volume":"8","author":"D Goletti","year":"2007","unstructured":"Goletti D, Parracino MP, Butera O et al (2007) Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study. Respir Res 8:5","journal-title":"Respir Res"},{"issue":"3","key":"2669_CR20","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1440-1843.2008.01244.x","volume":"13","author":"K Higuchi","year":"2008","unstructured":"Higuchi K, Harada N, Mori T (2008) Interferon-\u03b3 responses after isoniazid chemotherapy for latent tuberculosis. Respirology 13(3):468\u2013472","journal-title":"Respirology"},{"issue":"4 Pt 2","key":"2669_CR21","first-page":"S221","volume":"161","author":"American Thoracic Society, Centers for Disease Control and Prevention","year":"2000","unstructured":"American Thoracic Society, Centers for Disease Control and Prevention (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 161(4 Pt 2):S221\u2013S247","journal-title":"Am J Respir Crit Care Med"},{"issue":"12 Suppl 3","key":"2669_CR22","first-page":"384","volume":"7","author":"J Jereb","year":"2003","unstructured":"Jereb J, Etkind SC, Joglar OT, Moore M, Taylor Z (2003) Tuberculosis contact investigations: outcomes in selected areas of the United States, 1999. Int J Tuberc Lung Dis 7(12 Suppl 3):384\u2013390","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"2669_CR23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1164\/rccm.200303-390OC","volume":"168","author":"PA LoBue","year":"2003","unstructured":"LoBue PA, Moser KS (2003) Use of isoniazid for latent tuberculosis infection in a public health clinic. Am J Respir Crit Care Med 168(4):443\u2013447","journal-title":"Am J Respir Crit Care Med"},{"issue":"20","key":"2669_CR24","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1056\/NEJMsa031667","volume":"350","author":"CR Horsburgh Jr","year":"2004","unstructured":"Horsburgh CR Jr (2004) Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 350(20):2060\u20132067","journal-title":"N Engl J Med"},{"issue":"2","key":"2669_CR25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1378\/chest.09-0394","volume":"137","author":"CR Horsburgh Jr","year":"2010","unstructured":"Horsburgh CR Jr, Goldberg S, Bethel J, Tuberculosis Epidemiologic Studies Consortium et al (2010) Latent TB infection treatment acceptance and completion in the United States and Canada. Chest 137(2):401\u2013409","journal-title":"Chest"},{"key":"2669_CR26","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1183\/09031936.02.00309102","volume":"36","author":"MD Iseman","year":"2002","unstructured":"Iseman MD (2002) Tuberculosis therapy: past, present and future. Eur Respir J 36:S87\u2013S94","journal-title":"Eur Respir J"},{"issue":"6","key":"2669_CR27","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/clinids\/17.6.968","volume":"17","author":"RE Huebner","year":"1993","unstructured":"Huebner RE, Schein MF, Bass JB Jr (1993) The tuberculin skin test. Clin Infect Dis 17(6):968\u2013975","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2669_CR28","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/ard.2004.029041","volume":"64","author":"D Ponce de Le\u00f3n","year":"2005","unstructured":"Ponce de Le\u00f3n D, Acevedo-V\u00e1squez E, S\u00e1nchez-Torres A et al (2005) Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis. Ann Rheum Dis 64(9):1360\u20131361","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2669_CR29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ymeth.2012.12.012","volume":"61","author":"HS Whitworth","year":"2013","unstructured":"Whitworth HS, Scott M, Connell DW, Dong\u00e9s B, Lalvani A (2013) IGRAs\u2014the gateway to T cell based TB diagnosis. Methods 61(1):52\u201362","journal-title":"Methods"},{"issue":"6","key":"2669_CR30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/670635","volume":"34","author":"CL Daley","year":"2013","unstructured":"Daley CL, Reves RR, Beard MA et al (2013) A summary of meeting proceedings on addressing variability around the cut point in serial interferon-\u03b3 release assay testing. Infect Control Hosp Epidemiol 34(6):625\u2013630","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"2669_CR31","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","volume":"7","author":"CE Barry 3rd","year":"2009","unstructured":"Barry CE 3rd, Boshoff HI, Dartois V et al (2009) The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 7(12):845\u2013855","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"2669_CR32","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1183\/09031936.00114810","volume":"37","author":"M Sester","year":"2011","unstructured":"Sester M, Sotgiu G, Lange C et al (2011) Interferon-\u03b3 release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 37(1):100\u2013111","journal-title":"Eur Respir J"},{"key":"2669_CR33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","volume":"19","author":"JL Flynn","year":"2001","unstructured":"Flynn JL, Chan J (2001) Immunology of tuberculosis. Annu Rev Immunol 19:93\u2013129","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"2669_CR34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/156652407780598557","volume":"7","author":"GA Rook","year":"2007","unstructured":"Rook GA (2007) Th2 cytokines in susceptibility to tuberculosis. Curr Mol Med 7(3):327\u2013337","journal-title":"Curr Mol Med"},{"issue":"40","key":"2669_CR35","doi-asserted-by":"crossref","first-page":"33656","DOI":"10.1074\/jbc.M112.375154","volume":"287","author":"VP Dwivedi","year":"2012","unstructured":"Dwivedi VP, Bhattacharya D, Chatterjee S et al (2012) Mycobacterium tuberculosis directs T helper 2 cell differentiation by inducing interleukin-1\u03b2 production in dendritic cells. J Biol Chem 287(40):33656\u201333663","journal-title":"J Biol Chem"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2669-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-014-2669-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2669-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T17:16:48Z","timestamp":1716743808000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-014-2669-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,15]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["2669"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2669-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,15]]}}}